These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8838260)

  • 1. Oral morphine termed narcotic standard in severe cancer pain.
    Oncology (Williston Park); 1996 Feb; 10(2):186, 189. PubMed ID: 8838260
    [No Abstract]   [Full Text] [Related]  

  • 2. Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.
    Tani M; Fuku A; Terashita S; Kashiwagi H; Yukawa H; Yamaue H
    Hepatogastroenterology; 2008; 55(86-87):1545-8. PubMed ID: 19102339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer patient care--management of intractable pain in patients with cancers].
    Takeda F
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):360-4. PubMed ID: 8690995
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transdermal route as an alternative to oral administration of opioids in cancer pain].
    Burza M; Ginobbi P; Fusco G; Laurenzi L; Tirelli W; Arcuri E
    Clin Ter; 1998; 149(4):277-80. PubMed ID: 9866889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
    Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
    Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Breakthrough pain frequency in cancer patients and the efficiency of oral transmucosal fentanyl citrate].
    Bilen A; Ali A; Baturay F; Altan A
    Agri; 2010 Jul; 22(3):103-8. PubMed ID: 20865581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report].
    Shinjo T; Okada M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1997-2000. PubMed ID: 16282744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do patients prefer transdermal fentanyl or sustained-release oral morphine for treatment of chronic non-cancer pain?
    Heidemann AJ; Seaton TL
    J Fam Pract; 2001 Oct; 50(10):897. PubMed ID: 11674896
    [No Abstract]   [Full Text] [Related]  

  • 10. New developments in palliative medicine.
    Loughrey E
    Ir Med J; 1997 Oct; 90(6):221. PubMed ID: 9611920
    [No Abstract]   [Full Text] [Related]  

  • 11. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cancer-related pain with transdermal fentanyl.
    Leelanuntakit S
    J Med Assoc Thai; 1996 Jun; 79(6):341-6. PubMed ID: 8855606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong analgesics in severe pain.
    Gourlay GK; Cousins MJ
    Drugs; 1984 Jul; 28(1):79-91. PubMed ID: 6146508
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of morphine slow release tablet (MST) and morphine sulphate solution (MSS) in the treatment of cancer pain.
    Panich A; Charnvej L
    J Med Assoc Thai; 1993 Dec; 76(12):672-6. PubMed ID: 7798818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Direct conversion from low-dose morphine to transdermal fentanyl: efficacy for cancer pain and quality of life].
    Yamazaki M; Aoki T; Tachibana M; Akashi T
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):217-21. PubMed ID: 16484859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pain therapy. Treating pain patients with opioid preparations].
    MMW Fortschr Med; 2013 Apr; 155(6):70-1. PubMed ID: 23700704
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parenteral opioids in end-of-life care in cancer patients].
    Hattori S; Kimura N; Takatani J; Noguchi T
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):161-6. PubMed ID: 15751626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments on Ripamonti et al., Pain, 70 (1997) 109-115.
    Morley JS; Makin MK
    Pain; 1997 Oct; 73(1):114-5. PubMed ID: 9414068
    [No Abstract]   [Full Text] [Related]  

  • 20. Opioid titration with sustained-release oxycodone and immediate-release morphine for moderate/severe cancer pain: a pilot assessment of the CoDem protocol.
    Samolsky Dekel BG; Tomasi M; Vasarri A; Gori A; Adversi M; Castagnoli A; Di Nino G; Melotti RM
    J Opioid Manag; 2014; 10(1):29-38. PubMed ID: 24604567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.